← Evidence map

ArticleEuropean urology2019

Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial.

Derya Tilki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019

this papercites it

Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial. | OpenQuestion